SMARCA4 and lung carcinoma: In lung cancer and other solid tumors, deficiency of key SWI/SNF subunits (such as SMARCA4/BRG1) profoundly reorganizes chromatin architecture and transcriptional circuitry, thereby reshaping cellular sensitivity to multiple anticancer agents.